FDA Heads Back to Work, for Now
The latest continuing resolution funds the government for three weeks.
After a three-day government shutdown due to a budget stalemate in Congress, FDA and other government employees resumed work on Jan. 23, 2018. On Monday, Jan. 22, approximately 40% of the FDA staff was furloughed due to the lack of funding for operations.
On Jan. 22, Congress approved, and President Trump signed, a continuing resolution that will fund the government through Feb. 8, 2018. Congress also funded the Children’s Health Insurance Program for six years and delayed taxes on medical device sales.
The funding extension was enacted after Senate leadership agreed to address the future of the Deferred Action for Childhood Arrivals (DACA) program, a program for people brought to the United States as minors, that is central to contentious debate to the nation’s immigration policy.
The Congress and the administration have three weeks to agree on funding for the government for the 2018 fiscal year, and to discuss DACA.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.
Regeneron Treatment for Multiple Myeloma Gets Conditional Marketing Approval from EC
April 29th 2025The indication is specific to patients who have received at least three prior therapies, including a proteasome inhibitor, immunomodulatory agent, and anti-CD38 monoclonal antibody, and have demonstrated disease progression on the last therapy.
